Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Gabapentin for Emergence Agitation after Rhinoplasty
NCT05626998Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Nov 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and gabapentin in Emergence agitation (EA), sponsored by Ain Shams University. Primary endpoint: Emergence Agitation at 1 hour. Started Nov 2022; status: completed.
02
Drugs
dexmedetomidinegabapentin
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT05626998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05626998.